Enveric Biosciences, Inc. (ENVB) は上場企業です ヘルスケア セクターの バイオテクノロジー 業界で事業展開. 本社所在地は Naples, FL, アメリカ. 現CEOは Joseph Edward Tucker.
ENVB を有する IPO日 2015-05-04, 5 名の正社員, に上場 NASDAQ Capital Marke, 時価総額 $1.16M.
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
